William Hartman, CEO of Premier Biomedical, Inc. (
Post# of 39272
Posted On: 07/08/2016 11:28:05 AM
William Hartman, CEO of Premier Biomedical, Inc. (OTCQB:BIEI) talks about how delighted he is with the anti-cancer drug PBI-5D3H5 has demonstrated great performance in the initial testing. He also mentioned how the testing has confirmed compatibility of the drug with human tissue. They expect testing to be concluded within the next several months. Read all about it here: https://upticknewswire.com/premier-biomedical...niversity/
(0)
(0)Scroll down for more posts ▼